
Discover the latest advancements in hidradenitis suppurativa therapies, including promising biologics and oral treatments reshaping patient care in 2025.

Discover the latest advancements in hidradenitis suppurativa therapies, including promising biologics and oral treatments reshaping patient care in 2025.

Erik Domingues leads a vital discussion on innovative vitiligo management, addressing treatment challenges and psychosocial impacts in diverse patient populations.

Hilary Baldwin, MD; Douglas DiRuggiero, DMSc, MHS, PA-C; Diego Ruiz DaSilva, MD; Ken Korber, PA-C; Patrick Burnett, MD, PhD; and Lisa Weiss, PA-C, share what gifts they would give to the field of dermatology this holiday season.

Experts discuss innovative strategies for vitiligo treatment, emphasizing the role of topical Janus kinase inhibitors and effective patient communication for optimal outcomes.

Discover how NPs and PAs shaped the future of dermatology this year as leaders inspire the next generation to thrive in their careers.

Michael O'Donoghue, MD, shares insights on actinic keratosis management, emphasizing personalized therapy strategies.

At a recent Case-Based Roundtable event, Harrison Nguyen, MD, MBA, MPH, reviewed 2 HS patient cases and discussed the role of biologics.

Find out what skin care products and aesthetic innovations clinicians have recommended to patients in 2025.


A mother shares her personal journey with her daughter's chronic spontaneous urticaria, highlighting the emotional and treatment challenges faced by families.

Explore our top performing social media posts of 2025, including insights on the latest clinical trials, FDA approvals, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

In case you missed it, this week we had news on phase 3 data for zasocitinib in psoriasis, wildfire air pollution's impact on AD clinic visits, the FDA's clearance of REX-8756's IND application, and more.

In part 3 of this supplement, experts discuss treatment options for adults with hormonal pattern acne and PIH.

Discover effective treatment strategies for keloids and hypertrophic scars in skin of color, emphasizing personalized approaches and combination therapies.

Energy and protein drinks may exacerbate acne through high sugar and insulin levels, impacting skin health among athletes and students.

Discover the latest trends in aesthetic dermatology for 2025, including innovative treatments and the impact of social media on patient choices.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of December.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed the 3 latest non-steroidal topicals for atopic dermatitis at the Horizons in Advanced Practice meeting.

Experts discuss real-world strategies for managing alopecia areata, emphasizing JAK inhibitors, psychosocial impacts, and personalized patient care approaches.

What were the top dermatology hits of 2025?

In part 3 of this Case-Based Roundtable supplement, experts discuss psoriatic therapies for hair-baring areas.

Omar Noor, MD, recently presented 3 cases of psoriasis in older patients at Horizons in Advanced Practice to discuss available treatment options and considerations for Medicare and in-office injections.

A study reveals stress coping strategies and eosinophil levels impact CU in adolescents, highlighting the need for integrated psychological support.

Explore the risks of bypassing dermatologists for DIY skin care and telehealth treatments, highlighting real patient experiences and expert insights.

Zasocitinib emerges as a promising oral therapy for psoriasis, achieving significant skin clearance and favorable safety in recent phase 3 trials.

At a recent Case-Based Roundtable® event, Aaron Farberg, MD, moderated a discussion of challenging atopic dermatitis cases spanning adult, adolescent, and pediatric patients.

In part 2 of this supplement, experts discuss therapies for inflammatory acne